Literature DB >> 23543758

Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08:01 and DRB1*11:01 Is predicted by their structural motifs and correlates with disease risk.

I-Ting Chow1, Eddie A James, Theresa J Gates, Venus Tan, Antonis K Moustakas, George K Papadopoulos, William W Kwok.   

Abstract

DRB1*08:01 (DR0801) and DRB1*11:01 (DR1101) are highly homologous alleles that have opposing effects on susceptibility to primary biliary cirrhosis (PBC). DR0801 confers risk and shares a key feature with other HLA class II alleles that predispose to autoimmunity: a nonaspartic acid at beta57. DR1101 is associated with protection from PBC, and its sequence includes an aspartic acid at beta57. To elucidate a mechanism for the opposing effects of these HLA alleles on PBC susceptibility, we compared the features of epitopes presented by DR0801 and DR1101. First, we identified DR0801- and DR1101-restricted epitopes within multiple viral Ags, observing both shared and distinct epitopes. Because DR0801 is not well characterized, we deduced its motif by measuring binding affinities for a library of peptides, confirming its key features through structural modeling. DR0801 was distinct from DR1101 in its ability to accommodate charged residues within all but one of its binding pockets. In particular, DR0801 strongly preferred acidic residues in pocket 9. These findings were used to identify potentially antigenic sequences within PDC-E2 (an important hepatic autoantigen) that contain a DR0801 motif. Four peptides bound to DR0801 with reasonable affinity, but only one of these bound to DR1101. Three peptides, PDC-E2145-159, PDC-E2(249-263), and PDC-E2(629-643), elicited high-affinity T cell responses in DR0801 subjects, implicating these as likely autoreactive specificities. Therefore, the unique molecular features of DR0801 may lead to the selection of a distinct T cell repertoire that contributes to breakdown of self-tolerance in primary biliary cirrhosis, whereas those of DR1101 promote tolerance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543758      PMCID: PMC3729472          DOI: 10.4049/jimmunol.1202445

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.

Authors:  E J Novak; A W Liu; G T Nepom; W W Kwok
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  HLA-DR1001 presents "altered-self" peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets.

Authors:  Eddie A James; Antonis K Moustakas; John Bui; George K Papadopoulos; George Bondinas; Jane H Buckner; William W Kwok
Journal:  Arthritis Rheum       Date:  2010-10

3.  The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity.

Authors:  Kenji Yoshida; Adam L Corper; Rana Herro; Bana Jabri; Ian A Wilson; Luc Teyton
Journal:  J Clin Invest       Date:  2010-04-19       Impact factor: 14.808

4.  The peptide-binding motif of HLA-DR8 shares important structural features with other type 1 diabetes-associated alleles.

Authors:  L Muixí; M Gay; P M Muñoz-Torres; C Guitart; J Cedano; J Abian; I Alvarez; D Jaraquemada
Journal:  Genes Immun       Date:  2011-06-09       Impact factor: 2.676

Review 5.  Primary biliary cirrhosis: what do autoantibodies tell us?

Authors:  Chao-Jun Hu; Feng-Chun Zhang; Yong-Zhe Li; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

Review 6.  Human leukocyte antigen in primary biliary cirrhosis: an old story now reviving.

Authors:  Pietro Invernizzi
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

Review 7.  Linking human beta retrovirus infection with primary biliary cirrhosis.

Authors:  A L Mason; G Zhang
Journal:  Gastroenterol Clin Biol       Date:  2010-06-30

Review 8.  Primary biliary cirrhosis.

Authors:  Douglas L Nguyen; Brian D Juran; Konstantinos N Lazaridis
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-10       Impact factor: 3.043

9.  Frequency of epitope-specific naive CD4(+) T cells correlates with immunodominance in the human memory repertoire.

Authors:  William W Kwok; Venus Tan; Laurie Gillette; Christopher T Littell; Michele A Soltis; Rebecca B LaFond; Junbao Yang; Eddie A James; Jonathan H DeLong
Journal:  J Immunol       Date:  2012-02-10       Impact factor: 5.422

10.  The binding of antigenic peptides to HLA-DR is influenced by interactions between pocket 6 and pocket 9.

Authors:  Eddie A James; Antonis K Moustakas; John Bui; Randi Nouv; George K Papadopoulos; William W Kwok
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

View more
  6 in total

1.  Inflammation-Induced Citrullinated Glucose-Regulated Protein 78 Elicits Immune Responses in Human Type 1 Diabetes.

Authors:  Mijke Buitinga; Aïsha Callebaut; Fernanda Marques Câmara Sodré; Inne Crèvecoeur; Gabriele Blahnik-Fagan; Mei-Ling Yang; Marco Bugliani; David Arribas-Layton; Meghan Marré; Dana P Cook; Etienne Waelkens; Roberto Mallone; Jon D Piganelli; Piero Marchetti; Mark J Mamula; Rita Derua; Eddie A James; Chantal Mathieu; Lut Overbergh
Journal:  Diabetes       Date:  2018-11       Impact factor: 9.461

2.  Broad-Based CD4+ T Cell Responses to Influenza A Virus in a Healthy Individual Who Lacks Typical Immunodominance Hierarchy.

Authors:  Li Chen; Anjaleena Anthony; Sara Oveissi; Miaojuan Huang; Damien Zanker; Kun Xiao; Chao Wu; Quanming Zou; Weisan Chen
Journal:  Front Immunol       Date:  2017-04-03       Impact factor: 7.561

3.  Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines.

Authors:  Channakeshava Sokke Umeshappa; Santiswarup Singha; Jesus Blanco; Kun Shao; Roopa Hebbandi Nanjundappa; Jun Yamanouchi; Albert Parés; Pau Serra; Yang Yang; Pere Santamaria
Journal:  Nat Commun       Date:  2019-05-14       Impact factor: 14.919

4.  Recognition of posttranslationally modified GAD65 epitopes in subjects with type 1 diabetes.

Authors:  John W McGinty; I-Ting Chow; Carla Greenbaum; Jared Odegard; William W Kwok; Eddie A James
Journal:  Diabetes       Date:  2014-04-04       Impact factor: 9.461

Review 5.  The immunogenetics of primary biliary cirrhosis: A comprehensive review.

Authors:  G J Webb; K A Siminovitch; G M Hirschfield
Journal:  J Autoimmun       Date:  2015-08-03       Impact factor: 7.094

6.  Amino acid residues in five separate HLA genes can explain most of the known associations between the MHC and primary biliary cholangitis.

Authors:  Rebecca Darlay; Kristin L Ayers; George F Mells; Lynsey S Hall; Jimmy Z Liu; Mohamed A Almarri; Graeme J Alexander; David E Jones; Richard N Sandford; Carl A Anderson; Heather J Cordell
Journal:  PLoS Genet       Date:  2018-12-03       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.